Particle.news
Download on the App Store
3 ARTICLES
·
4w ago

BC Investments IV to Sell 2.4% Stake in Emcure Pharma Through Block Deal

Kotak Securities will lead the offer at a floor price of Rs 1,279.80 per share to tap into recent share price swings.

Image
Image
Image

Overview

  • BC Investments IV, the Bain Capital–affiliated fund, plans to divest 2.4% of Emcure Pharma via a block deal involving 45.5 lakh shares.
  • The block trade is pegged at about Rs 551 crore with the floor price set just below the previous close of Rs 1,280.30.
  • Emcure reported a 63% year-on-year rise in consolidated net profit to Rs 197 crore and a 19.5% revenue increase to Rs 2,116 crore in Q4 FY25.
  • Emcure’s stock has slipped 4% over the past month and is nearly 13% lower year-to-date, trading about 19% below its September 2024 peak.
  • Since its July 2024 IPO raised Rs 1,952 crore, Emcure’s shares have gained about 27% above their issue price as the company pursues global growth.